Header cover image

U.S. Biotech Industry Analysis

UpdatedNov 30, 2022
DataAggregated Company Financials
Companies638
  • 7D-1.0%
  • 3M12.1%
  • 1Y-15.2%
  • YTD-11.9%

In the last week, the Biotech industry is down 1.0% with AbbVie down the most at 1.0%. The industry has fallen 15% in the last year. Earnings are forecast to grow by 9.4% annually.

Industry Valuation and Performance

Has the U.S. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 30 Nov 2022US$1.1tUS$202.2bUS$1.3b14.6x876.7x5.5x
Fri, 28 Oct 2022US$1.1tUS$205.5bUS$7.3b14x147.6x5.3x
Sun, 25 Sep 2022US$1.0tUS$206.0bUS$5.6b13.9x182.3x4.9x
Tue, 23 Aug 2022US$1.1tUS$206.2bUS$7.2b15.6x147.4x5.2x
Thu, 21 Jul 2022US$1.1tUS$211.6bUS$10.7b17.1x101.1x5.1x
Sat, 18 Jun 2022US$922.9bUS$212.2bUS$10.9b14.8x84.4x4.3x
Mon, 16 May 2022US$993.9bUS$212.0bUS$10.6b15.6x94.1x4.7x
Wed, 13 Apr 2022US$1.3tUS$226.8bUS$14.9b18.2x85.4x5.6x
Fri, 11 Mar 2022US$1.2tUS$222.2bUS$10.6b19x114.6x5.5x
Sun, 06 Feb 2022US$1.3tUS$216.1bUS$6.6b21.5x190.2x5.8x
Tue, 04 Jan 2022US$1.4tUS$211.9bUS$2.8b26x519.5x6.8x
Thu, 02 Dec 2021US$1.5tUS$212.0bUS$3.1b24.9x469.3x6.9x
Sat, 30 Oct 2021US$1.5tUS$195.9b-US$3,061,505,326.0025.3x-491.2x7.7x
Mon, 27 Sep 2021US$1.6tUS$196.4b-US$2,419,608,414.0024.9x-653.6x8.1x
Wed, 25 Aug 2021US$1.6tUS$197.0b-US$1,662,914,785.5821.9x-957.4x8.1x
Thu, 01 Jul 2021US$1.5tUS$196.9b-US$825,939,314.8425.2x-1810.8x7.6x
Sun, 04 Apr 2021US$1.4tUS$174.8b-US$10,804,700,199.5520.3x-125.6x7.8x
Wed, 06 Jan 2021US$1.3tUS$162.7b-US$10,861,442,801.1419.2x-121.1x8.1x
Sat, 10 Oct 2020US$1.2tUS$150.3b-US$4,331,812,814.8820.2x-265.6x7.7x
Fri, 03 Jul 2020US$1.1tUS$138.4b-US$4,989,424,690.2920.9x-226.8x8.2x
Mon, 06 Apr 2020US$726.8bUS$100.1b-US$4,690,733,128.4215.6x-154.9x7.3x
Thu, 09 Jan 2020US$764.7bUS$98.3b-US$448,688,283.2314.7x-1704.4x7.8x
Price to Earnings Ratio

-269.2x


Total Market Cap: US$757.8bTotal Earnings: -US$2,815,023,937.85Total Revenue: US$96.7bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Biotech Industry Price to Earnings3Y Average -223.6x202020212022
Current Industry PE
  • Investors are optimistic on the American Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 877x which is higher than its 3-year average PE of -224x.
  • The 3-year average PS ratio of 7.1x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 28% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.94%
Healthcare-0.045%
Biotech-1.00%
Biotech-1.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BNTX BioNTechUS$163.613.1%
+US$1.2b
-53.5%PE3.7x
BMRN BioMarin PharmaceuticalUS$97.126.5%
+US$1.1b
12.6%PE215.1x
GILD Gilead SciencesUS$85.760.6%
+US$664.7m
24.4%PE32.3x
HALO Halozyme TherapeuticsUS$57.056.4%
+US$462.4m
73.5%PE36.5x
SRPT Sarepta TherapeuticsUS$117.104.6%
+US$449.4m
44.9%PS11.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

RCUS

US$30.51

Arcus Biosciences

7D

12.3%

1Y

-30.3%

SRPT

US$117.10

Sarepta Therapeutics

7D

4.6%

1Y

44.9%

REGN

US$736.08

Regeneron Pharmaceuticals

7D

-1.8%

1Y

15.6%

ALNY

US$204.79

Alnylam Pharmaceuticals

7D

-2.2%

1Y

11.4%

BMRN

US$97.12

BioMarin Pharmaceutical

7D

6.5%

1Y

12.6%

BIIB

US$291.41

Biogen

7D

-5.0%

1Y

23.6%

ABBV

US$158.20

AbbVie

7D

-1.0%

1Y

37.2%

BGNE

US$179.86

BeiGene

7D

1.9%

1Y

-48.2%

SGEN

US$117.37

Seagen

7D

-5.8%

1Y

-26.6%

BNTX

US$163.61

BioNTech

7D

3.1%

1Y

-53.5%

HALO

US$57.05

Halozyme Therapeutics

7D

6.4%

1Y

73.5%

AMGN

US$281.99

Amgen

7D

-1.8%

1Y

41.8%

VRTX

US$316.33

Vertex Pharmaceuticals

7D

-1.6%

1Y

69.2%

MRNA

US$173.15

Moderna

7D

-3.6%

1Y

-50.9%